Etrasimod demonstrates long-term response, remission in ulcerative colitis

January 8, 2019
Etrasimod — an oral, selective sphingosine 1 phosphate receptor modulator — demonstrated durable clinical remission in the treatment of…
In the Journals

Comorbidities, not age linked to immunomodulator use in IBD

December 31, 2018
Physicians should be careful when prescribing immunomodulator therapy to patients with inflammatory bowel disease who have higher comorbid status…
In the Journals

Antidepressants could impact disease course in IBD

December 27, 2018
Antidepressants could be a beneficial therapy for patients with inflammatory bowel disease for symptoms beyond anxiety and depression, according to…


Target PharmaSolutions, Bristol-Myers Squibb partner to advance IBD research

December 8, 2018
Target PharmaSolutions has announced a strategic partnership with Bristol-Myers Squibb to conduct a longitudinal observational study that will…

10 IBD updates for Crohn’s and Colitis Awareness Week

December 4, 2018
December 1 to December 7 marks Crohn’s & Colitis Awareness Week. First created by U.S. Senate Resolution 199 in November 2011, this…
In the Journals

Consultation improves vaccination rates for patients with IBD, GI cancers

December 3, 2018
A single visit with a consultant helped improve vaccination knowledge and coverage among patients with inflammatory bowel disease or gastrointestinal…

First-in-human study to evaluate safety, tolerability of therapy for ulcerative colitis

November 30, 2018
OSE Immunotherapeutics has received authorization to initiate a phase 1 clinical trial of OSE-127, a monoclonal antibody targeting the IL-7 receptor…
In the Journals

Xeljanz appears safe for UC treatment despite herpes zoster risk

November 29, 2018
Xeljanz — a small-molecule Janus kinase inhibitor — appeared safe for the treatment of patients with moderate-to-severe ulcerative…
In the Journals

Abrilumab induces remission, healing in moderate to severe UC

November 26, 2018
Abrilumab, an anti-alpha-4 beta-7 antibody, helped induce remission, clinical response and mucosal healing in patients with moderate to severe…